Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs
Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Home
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • ATMP
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Product information
    • Regulatory procedures
  • Veterinary
  • CPD supplements
    • Back to parent navigation item
    • CPD supplements
    • 2021/2022
    • 2020
    • 2019
  • Interviews
  • Meetings reports
    • Back to parent navigation item
    • Meetings reports
    • Symposium 2022
      • Back to parent navigation item
      • Symposium 2022
      • Human Medicines
      • Medical Devices/IVDs
      • Veterinary Medicines
      • Annual Lecture
    • Symposium 2021
      • Back to parent navigation item
      • Symposium 2021
      • Human Medicines
      • Medical Devices/IVDs
      • Veterinary Medicines
      • Annual Lecture
  • Editorials
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs
  • Home
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
    • Understanding the key components of a clinical evaluation
      Understanding key components
      of a clinical evaluation
    • AdobeStock_497948986 (1)
      Successful transition of your ISO 13485 QMS from MDD/IVDD to MDR/IVDR
    • AdobeStock_337955476 (1)
      Medical Device Standards Update
  • Pharmaceuticals
      • ATMP
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Product information
      • Regulatory procedures
    • Medical Device Regulation
      European medicines and medical devices:
      Future trends
    • AdobeStock_507177586
      A View of…The Environmental Impact of Pharmaceuticals
    • Patient information, why do things go wrong?
      Patient information — why do things go wrong?
  • Veterinary
  • CPD supplements
      • 2021/2022
      • 2020
      • 2019
    • AdobeStock_507759233
      FDA meetings: How to hold a successful meeting across the drug development lifecycle
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
    • AdobeStock_207448226
      Digital health technologies – an overview of EU and US frameworks
  • Interviews
  • Meetings reports
      • Symposium 2022
        • Human Medicines
        • Medical Devices/IVDs
        • Veterinary Medicines
        • Annual Lecture
      • Symposium 2021
        • Human Medicines
        • Medical Devices/IVDs
        • Veterinary Medicines
        • Annual Lecture
  • Editorials
  • More navigation items

Editorial

Setting the right standards

Setting the right standards

By Nancy Pire-Smerkanich, Stephen Dew

Editor's pick

  • Previous
  • Next
  • Science is more than you think

    ‘Science is more than a body of knowledge.
    It’s a way of thinking’*

  • wheelchair professional

    A regulatory lens on an industry imperative: Diversity in clinical research

  • cancer therapy

    A review of Project Orbis: An initiative enabling faster patient access to cancer therapies

  • Brexit supply chain

    Brexit − Regulatory and supply chain considerations

  • Medical Device Regulation

    European medicines and medical devices:
    Future trends

  • AdobeStock_228931204

    Evolutions in patient healthcare at the MHRA

  • hemp

    Hype over hemp as a veterinary feed additive?

  • medicines

    Regulating medicines in a surge of change

Latest Journal

Direct healthcare professional communication as an intervention tool – retrospective analysis

Direct healthcare professional communication as an intervention tool – retrospective analysis

By Ekaterina Pope

Is consulting in regulatory affairs your next career path?

Is consulting in regulatory affairs your next career path?

By Sequita Lindsey

EMA’s IDMP-SPOR Implementation Guideline v2.1.1

EMA’s IDMP-SPOR Implementation Guideline v2.1.1

By Vikrant Mahajan

Environmental impact of pharmaceuticals and regulation in the EU

Environmental impact of pharmaceuticals and regulation in the EU

By Paul Kuiken, Caolan McGuinness

...

Read By Issue

  • Previous
  • Next
  • RR-Mar-2023-COVER-300px

    March 2023

  • Regulatory Rapporteur February 2023

    February 2023

  • RR-Jan-2023-300x

    January 2023

  • RR-Cover-Dec-2022-300px

    December 2022

  • RR NOV22 Cover 300px

    November 2022

  • Screenshot 2022-09-16 102721

    October 2022

  • September 2022 cover 300px

    September 2022

  • JulyAugust 2022

    July/August 2022

  • June 22

    June 2022

  • May 22

    May 2022

  • april 22

    April 2022

  • march 22

    March 2022

  • Feb 22

    February 2022

  • jan 22

    January 2022

  • December 21

    December 2021

  • search the archive (1)

    Search the archive

  • Regulatory Rapporteur Editorial board
  • Future focus topics
  • Glossary
  • Privacy policy
  • Search the archive
  • TOPRA membership
  • What is regulatory affairs?
  • ISSN 1742-8955

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, 6th Floor, 3 Harbour Exchange, South Quay, London E14 9GE, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium Tel: +32 (0) 2 808 72 70

  • Issues
  • Contact us
  • Topics A-Z
  • Contributors A-Z
  • © 2023 Regulatory Rapporteur

Site powered by Webvision Cloud